Elevance Health, known for the vast majority of its history as Anthem, is a, complex leviathan built entirely around the bizarre, fragmented structure of the American healthcare system. The company traces its roots to 1944 when it was formed as Associated Hospital Service in Indiana, part of the nascent, non-profit Blue Cross network designed to help teachers afford hospital care. In the late 20th century, the company executed a major, controversial pivot: it "demutualized," abandoning its non-profit status to become a prominent, publicly traded, for-profit insurance corporation, allowing it to raise amounts of capital on Wall Street.
The Blue Cross Blue Shield Monopoly
The foundational asset of Elevance Health is its licensing agreement with the Blue Cross Blue Shield Association. Elevance holds the exclusive right to sell Blue Cross Blue Shield branded policies in 14 substantial states (including California, New York, and Ohio). In the complex world of healthcare, the "Blue" brand is powerful, synonymous with extensive hospital networks and trust. This exclusive licensing grants Elevance a near-monopoly in specific regional markets, allowing them to exert formidable negotiating leverage over local hospitals and doctors, driving down the rates they pay for medical procedures to protect their formidable profit margins.
The Cigna Megamerger Collapse
In 2015, operating under the assumption that extensive scale was the only way to survive the implementation of the Affordable Care Act (Obamacare), Anthem announced a staggering $54 billion megamerger with its rival, Cigna. The deal would have created the undisputed largest health insurer in the United States. However, the merger was a catastrophic, acrimonious failure. The US Department of Justice sued to block the deal, arguing it would create a large monopoly that would reduce competition and raise prices for large corporate employers. Following the government block, Anthem and Cigna engaged in a bitter, multi-billion-dollar legal war over the breakup fee, severely damaging Anthem's M&A strategy.
The Pivot to Medicare Advantage
Blocked from executing formidable commercial mergers, Elevance pivoted its prominent cash flow toward the most lucrative, rapidly expanding segment of American healthcare: Medicare Advantage. As millions of "Baby Boomers" retire and enter the government-funded Medicare system, they increasingly opt for privatized "Advantage" plans managed by companies like Elevance. The federal government pays Elevance a, fixed monthly fee per senior. If Elevance can keep that senior healthy (or code their diagnoses to maximize government reimbursement), the profit margins are staggering. Elevance acquired smaller, specialized insurers (like America's 1st Choice) to rapidly scale this lucrative division.
The Carelon Vertical Integration
In 2022, Anthem officially changed its name to Elevance Health. The rebranding signaled a formidable strategic shift away from being purely a "health insurance" company toward being a vertically integrated "healthcare services" company (mimicking the extensive success of its rival, UnitedHealth Group). Elevance launched Carelon, a healthcare services brand that handles complex pharmacy benefits (PBM), behavioral health, and large healthcare IT operations. By forcing its insurance members to use its own in-house pharmacy and healthcare services, Elevance captures profit at multiple different stages of a single patient's medical journey, creating a complex, lucrative closed-loop financial ecosystem.
